These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 16951195

  • 1. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway.
    Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K.
    Cancer Res; 2006 Sep 01; 66(17):8788-95. PubMed ID: 16951195
    [Abstract] [Full Text] [Related]

  • 2. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
    Jang GY, Jeon JH, Cho SY, Shin DM, Kim CW, Jeong EM, Bae HC, Kim TW, Lee SH, Choi Y, Lee DS, Park SC, Kim IG.
    Oncogene; 2010 Jan 21; 29(3):356-67. PubMed ID: 19838207
    [Abstract] [Full Text] [Related]

  • 3. Tissue transglutaminase-mediated chemoresistance in cancer cells.
    Verma A, Mehta K.
    Drug Resist Updat; 2007 Jan 21; 10(4-5):144-51. PubMed ID: 17662645
    [Abstract] [Full Text] [Related]

  • 4. Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
    Brown KD.
    Breast Cancer Res Treat; 2013 Jan 21; 137(2):329-36. PubMed ID: 23224146
    [Abstract] [Full Text] [Related]

  • 5. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
    Verma A, Guha S, Wang H, Fok JY, Koul D, Abbruzzese J, Mehta K.
    Clin Cancer Res; 2008 Apr 01; 14(7):1997-2005. PubMed ID: 18381937
    [Abstract] [Full Text] [Related]

  • 6. Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.
    Kumar S, Mehta K.
    PLoS One; 2012 Apr 01; 7(11):e49321. PubMed ID: 23185316
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.
    Wang Y, Ande SR, Mishra S.
    BMC Cancer; 2012 Jul 03; 12():277. PubMed ID: 22759359
    [Abstract] [Full Text] [Related]

  • 8. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
    Kumar S, Donti TR, Agnihotri N, Mehta K.
    Int J Cancer; 2014 Jun 15; 134(12):2798-807. PubMed ID: 24477458
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P, Wang Z, Collighan RJ, Griffin M.
    Amino Acids; 2011 Oct 15; 41(4):909-21. PubMed ID: 21046178
    [Abstract] [Full Text] [Related]

  • 15. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
    Herman JF, Mangala LS, Mehta K.
    Oncogene; 2006 May 18; 25(21):3049-58. PubMed ID: 16449978
    [Abstract] [Full Text] [Related]

  • 16. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
    Nakashima H, Nakamura M, Yamaguchi H, Yamanaka N, Akiyoshi T, Koga K, Yamaguchi K, Tsuneyoshi M, Tanaka M, Katano M.
    Cancer Res; 2006 Jul 15; 66(14):7041-9. PubMed ID: 16849549
    [Abstract] [Full Text] [Related]

  • 17. Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.
    Han AL, Kumar S, Fok JY, Tyagi AK, Mehta K.
    Eur J Cancer; 2014 Jun 15; 50(9):1685-96. PubMed ID: 24656569
    [Abstract] [Full Text] [Related]

  • 18. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 20. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
    Kim DS, Park SS, Nam BH, Kim IH, Kim SY.
    Cancer Res; 2006 Nov 15; 66(22):10936-43. PubMed ID: 17108131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.